Joan L. Buss

1.2k total citations
22 papers, 1.1k citations indexed

About

Joan L. Buss is a scholar working on Hematology, Genetics and Nutrition and Dietetics. According to data from OpenAlex, Joan L. Buss has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Genetics and 9 papers in Nutrition and Dietetics. Recurrent topics in Joan L. Buss's work include Iron Metabolism and Disorders (11 papers), Trace Elements in Health (9 papers) and Hemoglobinopathies and Related Disorders (9 papers). Joan L. Buss is often cited by papers focused on Iron Metabolism and Disorders (11 papers), Trace Elements in Health (9 papers) and Hemoglobinopathies and Related Disorders (9 papers). Joan L. Buss collaborates with scholars based in Canada, United States and Sweden. Joan L. Buss's co-authors include Suzy V. Torti, Frank M. Torti, Prem Ponka, Brian B. Hasinoff, Bryan T. Greene, JoLyn Turner, John Wilkinson, Jiřı́ Neužil, Roy P. Planalp and Yan Jiao and has published in prestigious journals such as Blood, Biochemical Journal and FEBS Letters.

In The Last Decade

Joan L. Buss

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan L. Buss Canada 18 319 288 221 204 170 22 1.1k
Pavlína Hašková Czechia 18 193 0.6× 223 0.8× 81 0.4× 164 0.8× 151 0.9× 28 803
Teruyuki Kawabata Japan 19 430 1.3× 226 0.8× 96 0.4× 159 0.8× 83 0.5× 35 1.2k
G.L. Card United States 12 878 2.8× 147 0.5× 271 1.2× 196 1.0× 281 1.7× 19 1.5k
Shashank Masaldan Australia 14 850 2.7× 495 1.7× 127 0.6× 485 2.4× 162 1.0× 17 2.1k
Maria Rosário Almeida Portugal 29 1.5k 4.7× 415 1.4× 28 0.1× 160 0.8× 63 0.4× 63 1.9k
Olga Popelová Czechia 17 396 1.2× 455 1.6× 97 0.4× 132 0.6× 112 0.7× 25 1.6k
Marcella Coronnello Italy 22 696 2.2× 786 2.7× 44 0.2× 75 0.4× 504 3.0× 44 1.6k
Michael A. Cater Australia 21 709 2.2× 892 3.1× 213 1.0× 1.2k 5.8× 240 1.4× 28 2.5k
Vladimír Geršl Czechia 22 476 1.5× 545 1.9× 129 0.6× 190 0.9× 136 0.8× 52 2.0k
Ernst S. Henle United States 10 843 2.6× 129 0.4× 86 0.4× 165 0.8× 112 0.7× 11 1.4k

Countries citing papers authored by Joan L. Buss

Since Specialization
Citations

This map shows the geographic impact of Joan L. Buss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan L. Buss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan L. Buss more than expected).

Fields of papers citing papers by Joan L. Buss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan L. Buss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan L. Buss. The network helps show where Joan L. Buss may publish in the future.

Co-authorship network of co-authors of Joan L. Buss

This figure shows the co-authorship network connecting the top 25 collaborators of Joan L. Buss. A scholar is included among the top collaborators of Joan L. Buss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan L. Buss. Joan L. Buss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malisza, Krisztina L., et al.. (2015). Visual search for feature conjunctions: an fMRI study comparing alcohol-related neurodevelopmental disorder (ARND) to ADHD. Journal of Neurodevelopmental Disorders. 7(1). 10–10. 24 indexed citations
2.
Malisza, Krisztina L., et al.. (2012). Comparison of spatial working memory in children with prenatal alcohol exposure and those diagnosed with ADHD; A functional magnetic resonance imaging study. Journal of Neurodevelopmental Disorders. 4(1). 12–12. 36 indexed citations
3.
Szuber, Natasha, et al.. (2008). Alternative treatment paradigm for thalassemia using iron chelators. Experimental Hematology. 36(7). 773–785. 24 indexed citations
4.
Soe-Lin, Shan, Joan L. Buss, Evelyn Tang, & Prem Ponka. (2006). Calcein and the Labile Iron Pool.. Blood. 108(11). 1546–1546. 2 indexed citations
5.
Buss, Joan L., et al.. (2005). Mobilization of iron from cells by hydroxyquinoline-based chelators. Biochemical Pharmacology. 71(1-2). 214–222. 10 indexed citations
6.
Jiao, Yan, John Wilkinson, E. Christine Pietsch, et al.. (2005). Iron chelation in the biological activity of curcumin. Free Radical Biology and Medicine. 40(7). 1152–1160. 184 indexed citations
7.
Buss, Joan L., Bryan T. Greene, JoLyn Turner, Frank M. Torti, & Suzy V. Torti. (2004). Iron Chelators in Cancer Chemotherapy. Current Topics in Medicinal Chemistry. 4(15). 1623–1635. 165 indexed citations
8.
Buss, Joan L., et al.. (2003). Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells. Biochemical Pharmacology. 65(3). 349–360. 35 indexed citations
9.
Buss, Joan L. & Prem Ponka. (2003). Hydrolysis of pyridoxal isonicotinoyl hydrazone and its analogs. Biochimica et Biophysica Acta (BBA) - General Subjects. 1619(2). 177–186. 44 indexed citations
10.
Buss, Joan L., Jiřı́ Neužil, & Prem Ponka. (2003). Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs. Archives of Biochemistry and Biophysics. 421(1). 1–9. 35 indexed citations
11.
Buss, Joan L., Frank M. Torti, & Suzy V. Torti. (2003). The Role of Iron Chelation in Cancer Therapy. Current Medicinal Chemistry. 10(12). 1021–1034. 197 indexed citations
12.
Wang, Jian, Joan L. Buss, Guohua Chen, Prem Ponka, & Kostas Pantopoulos. (2002). The prolyl 4‐hydroxylase inhibitor ethyl‐3,4‐dihydroxybenzoate generates effective iron deficiency in cultured cells. FEBS Letters. 529(2-3). 309–312. 35 indexed citations
13.
Buss, Joan L., Marcelo Hermes‐Lima, & Prem Ponka. (2002). Pyridoxal Isonicotinoyl hydrazone and its analogues. Advances in experimental medicine and biology. 509. 205–229. 34 indexed citations
14.
Buss, Joan L., Jiřı́ Neužil, Nina Gellert, Christian Weber, & Prem Ponka. (2002). Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties. Biochemical Pharmacology. 65(2). 161–172. 39 indexed citations
15.
16.
Buss, Joan L., Jiřı́ Neužil, & Prem Ponka. (2002). The role of oxidative stress in the toxicity of pyridoxal isonicotinoyl hydrazone (PIH) analogues. Biochemical Society Transactions. 30(4). 755–758. 17 indexed citations
17.
Buss, Joan L. & Brian B. Hasinoff. (1997). Metal ion-promoted hydrolysis of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and its one-ring open hydrolysis products to its metal-chelating active form. Journal of Inorganic Biochemistry. 68(2). 101–108. 10 indexed citations
18.
Hasinoff, Brian B., et al.. (1996). The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells. Anti-Cancer Drugs. 7(5). 558–567. 34 indexed citations
19.
Buss, Joan L. & Brian B. Hasinoff. (1995). Ferrous Ion Strongly Promotes the Ring Opening of the Hydrolysis Intermediates of the Antioxidant Cardioprotective Agent Dexrazoxane (ICRF-187). Archives of Biochemistry and Biophysics. 317(1). 121–127. 19 indexed citations
20.
Buss, Joan L. & Brian B. Hasinoff. (1993). The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes. Inflammation Research. 40(1-2). 86–95. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pavlína Hašková Breakdown of academic impact, for papers by Teruyuki Kawabata Breakdown of academic impact, for papers by G.L. Card Breakdown of academic impact, for papers by Shashank Masaldan Breakdown of academic impact, for papers by Maria Rosário Almeida Breakdown of academic impact, for papers by Olga Popelová Breakdown of academic impact, for papers by Marcella Coronnello Breakdown of academic impact, for papers by Michael A. Cater Breakdown of academic impact, for papers by Vladimír Geršl Breakdown of academic impact, for papers by Ernst S. Henle
Rankless by CCL
2026